varicella

Sorivudine (BV-araU) has antiviral activity against several viruses including varicella zoster virus, herpes simplex type 1 virus, and Epstein-Barr virus by interfering with viral DNA synthesis.

CF-1743 is an anti-varicella zoster virus nucleoside and inhibits VZV replication. CF-1743 can be used in studies about infection of varicella and herpes zoster.

Valomaciclovir stearate (A-174606. 0) is a nucleoside analog with antiviral activity against varicella-zoster virus (VZV), and has been used in the study of VZV infections.

Netivudine is a potent nucleoside reverse transcriptase inhibitor (NRTIs), a nucleoside analogue with anti-varicella zoster virus activity that can be used to treat human immunodeficiency virus (HIV) infection. Netivudine works by inhibiting reverse transcriptase, which reduces viral load in the body and slows the progression of the disease through its inhibitory effect.

Acyclovir (Aciclovir) is a synthetic analog of the purine nucleoside, guanosine, with potent antiviral activity against herpes simplex viruses type 1 and 2, varicella-zoster virus and other viruses of the herpesvirus family.

Vidarabine (Adenine Arabinoside) is a nucleoside antibiotic isolated from Streptomyces antibioticus. It has some antineoplastic properties and has broad spectrum activity against DNA viruses in cell cultures and significant antiviral activity against infections caused by a variety of viruses such as the herpes viruses, the VACCINIA VIRUS and varicella zoster virus.

BRL44385 is an effective and selective inhibitor of the replication of HSV-1 and HSV2, Epstein-Barr virus (EBV), and varicella-zoster virus (VZV).

Lobucavir (BMS-180194; SQ 34514) is a nucleoside analogue and an antiviral agent with broad-spectrum activity against various viruses, including HBV, HIV AIDS, and α, β, and γ herpesviruses (including CMV, herpes simplex virus, varicella-zoster virus, and Epstein-Barr virus).

Denotivir (Vratizolin) is an orally active antiviral agent effective against herpes simplex virus (HSV) and varicella-zoster virus (VZV). It inhibits the proliferation of various cancer cells and possesses anti-leukemic properties. Additionally, Denotivir suppresses the production of TNF-α, IL-1, and IL-6, demonstrating immunosuppressive effects.

Vidarabine, a nucleoside antibiotic with antiviral acitivity that interferes with the synthesis of viral DNA, is used to treat varicella zoster and herpes simplex viruses.

A 73209 is a nucleoside analog of the oxetanocin family. A-73209 appears to be a potent and selective agent against herpes simplex virus and varicella-zoster virus infections.

Lysine Orotate is an inhibitor of viral replication, especially useful to treat the Herpes family of viruses which includes Herpes Simplex 1 and 2 , CMV, EBV and Varicella.

Valnivudine, a precursor of CF-1743, is an orally effective and highly effective anti-herpes zoster (HZ) nucleoside analogue, a bicyclic nucleoside analogue (BCNA). Valnivudine has antiviral activity and is highly inhibitory against varicella zoster virus (VZV). Valnivudine is rapidly and widely converted into CF-1743 in the body.

Insulin-degrading enzyme (IDE) is a thiol-sensitive zinc-metallopeptidase that acts as the major insulin-degrading protease in vivo, mediating the termination of insulin signaling. [1] In addition to regulating insulin action in diabetes pathogenesis, IDE plays a role in Varicella-Zoster virus infection and degradation of amyloid-β, a peptide implicated in Alzheimer's disease. ML-345 is a small molecule inhibitor that selectively targets cysteine819 in IDE with an EC50 value of 188 nM. [2] It demonstrates 10-fold selectivity for IDE over a panel of enzymes with reactive cysteine residues.[2] Reference:[1]. Maianti, J.P., McFedries, A., Foda, Z.H., et al. Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones. Nature 511(7507), 94-98 (2014).[2]. Bannister, T.D., Wang, H., Abdul-Hay, S.O., et al. ML345, a small-molecule inhibitor of the insulin-degrading enzyme (IDE). 1 R03 DA024888-01 (MLSCN cycle 6), 1-41 (2014).

Amenamevir (ASP2151) is a novel helicase-primase inhibitor that is active against varicella-zoster virus and herpes simplex virus types 1 and 2 (EC50: 14 ng/mL).

Biotin-PEG8-Vidarabine, a PEG-based linker containing the adenosine analog Vidarabine, functions as an antiviral agent effective against herpes simplex and varicella zoster viruses [1].

Biotin-PEG7-C2-S-Vidarabine is a polyethylene glycol (PEG)-based linker featuring Vidarabine, an adenosine analog and antiviral agent effective against herpes simplex and varicella zoster viruses [1].

Biotin-PEG7-C2-NH-Vidarabine-S-CH3 is a polyethylene glycol (PEG)-based linker that includes the adenosine analog Vidarabine, functioning as an antiviral agent against herpes simplex and varicella zoster viruses [1].

BVDU 5′-Triphosphate is an antiviral agent labeled with 5′-Triphosphate that specifically targets viral DNA polymerase. It exhibits outstanding selectivity for varicella-zoster virus (VZV) and herpes simplex virus type 1 (HSV-1) owing to its phosphorylation by the virus-specific thymidine kinase.

6-Methoxypurine arabinoside (Ara-m), a potent inhibitor of the varicella-zoster virus (VZV), exhibits 50% inhibitory concentrations (IC50) between 0.5 and 3 microM across eight VZV strains [1].

Acyclovir-d4 is a deuterated compound of Acyclovir. Acyclovir has a CAS number of 59277-89-3. Acyclovir is a synthetic analog of the purine nucleoside, guanosine, with potent antiviral activity against herpes simplex viruses type 1 and 2, varicella-zoster virus and other viruses of the herpesvirus family.

Isookanin shows strong diphenyl(2,4,6-trinitrophenyl)iminoazanium (DPPH) radical-scavenging activity with the IC50 value of 7.9 ± 0.53 μM. Isookanin is a potent inhibitor of α-amylase (IC50=0.447 mg/ml).